BARCLAYS PLC - ALX ONCOLOGY HLDGS INC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ALX ONCOLOGY HLDGS INC
ValueSharesWeighting
Q3 2023$129
-0.8%
26,964
+57.1%
0.00%
Q2 2023$130
+85.7%
17,168
+10.4%
0.00%
Q1 2023$70
-46.2%
15,547
+34.9%
0.00%
Q4 2022$130
-99.8%
11,528
+72.7%
0.00%
Q3 2022$64,000
+88.2%
6,677
+58.5%
0.00%
Q2 2022$34,000
-57.5%
4,213
-10.5%
0.00%
Q1 2022$80,0004,7070.00%
Other shareholders
ALX ONCOLOGY HLDGS INC shareholders Q4 2023
NameSharesValueWeighting ↓
venBio Partners LLC 9,699,925$46,559,64013.20%
Vivo Capital, LLC 4,220,048$20,256,2302.22%
Logos Global Management LP 1,000,000$4,800,0000.64%
Orbimed Advisors 2,871,000$13,780,8000.29%
Redmile Group, LLC 1,283,289$6,159,7870.29%
BRAIDWELL LP 1,249,900$5,999,5200.19%
Cormorant Asset Management, LP 612,079$2,937,9790.17%
Nan Fung Group Holdings Ltd 41,950$201,3600.16%
Forefront Analytics, LLC 13,769$66,0920.04%
CORNERCAP INVESTMENT COUNSEL INC 35,071$168,3410.03%
View complete list of ALX ONCOLOGY HLDGS INC shareholders